person
Lothar M.
- Country
- Germany
- Department
- Studienzentrum UnterEms
Research Overview
assignment
10
Clinical Trials ·
- A Comparative Study of ABP 234 and Pembrolizumab in Patients with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Phase III Randomized Controlled Trial of Abemaciclib Plus Endocrine Therapy Versus Endocrine Therapy in HR+/HER2- Early Breast Cancer with Intermediate to High Risk
- EORTC 2129-BCG: Elacestrant for treating ER+/HER2- breast cancer patients with ctDNA relapse (TREAT ctDNA)
location_city
1
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
148
Sites with multiple studies
Has run more than one trial at 148 of 475 partner sites.
Specializations
Lung Cancer Research
Specializes in the treatment of non-squamous non-small cell lung cancer, with particular focus on both early-stage disease and advanced/metastatic cases.
- Early-stage NSCLC management
- Post-surgical adjuvant therapy
- Advanced disease treatment approaches
Breast Cancer Studies
Conducts research in hormone receptor-positive breast cancer and HER2-positive breast cancer treatments, including novel therapeutic approaches.
- Adjuvant endocrine therapy
- HER2-targeted treatments
- Advanced breast cancer management
Colorectal Cancer Expertise
Focuses on metastatic colorectal cancer and rectal cancer treatment strategies, including surgical and therapeutic interventions.
- Post-resection therapy
- Organ preservation approaches
- Advanced disease management
- Stage II cancer treatment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.